| CDDW 2003 |
CAG POSTER SESSION A - SUNDAY
LIVER, BILIARY AND PANCREATIC DISORDERS
[033]
ENDOSCOPIC ULTRASOUND (EUS) vs STANDARD CARE FOR ACUTE BILIARY PANCREATITIS
(ABP): A COST-EFFECTIVENESS STUDY
J Romagnuolo1,
G Currie2
Depts. of Medicine1,
Community Health1,2, Economics2, University of Calgary,
Calgary, Alberta
[034]
GAIN OF FUNCTION MUTATION IN THE MULTISPECIFIC ORGANIC ANION TRANSPORTER Abcc2
MARKEDLY INCREASES MURINE CHOLESTEROL GALLSTONE PREVALENCE
Guylaine Bouchard, Stéphanie
Casavant, Ron Korstanje, Martin C Carey, Beverly Paigen
Division of Gastroenterology
and Nutrition, Ste-Justine Hospital, University of Montreal, Montreal, Quebec;
Division of Gastroenterology, Brigham and Women's Hospital, Harvard Medical
School, Boston, Massachusetts; and The Jackson Laboratory, Bar Harbor, Maine,
USA
[035]
PROCOLLAGEN TYPE III PEPTIDE AND METAVIR ANALYSIS OF HEPATIC HISTOLOGY IN THE
FIBROSIS OF HEPATITIS C
S Bloom, KM Peltekian, TC Peterson
Departments
of Medicine and Pharmacology. Dalhousie University, Halifax, Nova Scotia
[036]
CLONING AND CHARACTERIZATION OF A BETARETROVIRUS INFECTION IN PATIENTS WITH
PRIMARY BILIARY CIRRHOSIS
Lizhe Xu1, Zhiwei Shen1,
Adrian Keogh2, James Neuberger2, Andrew Mason3
1Department
of Medicine, Ochsner Clinic, Los Angeles, USA; 2Department of Medicine,
University Hospital, Birmingham, UK; 3Department of Medicine, University
of Alberta, Alberta
[037]
APPLICATION OF THE MAYO MODEL FOR END STAGE LIVER DISEASE (MELD) SCORE IN PREDICTING
LIVER TRANSPLANT OUTCOMES
S Bazarah, K Peltekian, S Patel, H MacKinnon,
V McAlister*, H Bitter-Suermann, AS MacDonald
Atlantic Liver
Transplantation Program, Dalhousie University, Halifax, Nova Scotia, and *London
Health Sciences Centre, London, Ontario
[038]
LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS (PSC)
E Solano, D Stell, A Khakhar, C Ghent, W
Wall, P Marotta
MOTS Unit, London Health
Sciences Centre, London, Ontario
[039]
THE QUANTITATIVE PANCREATIC STIMULATION TEST - FACTORS THAT INFLUENCE VALIDITY
Susanne Schibli1, Mary Corey2,
Peter Durie2
The Hospital for Sick Children
and University of Toronto, Toronto, Ontario
[040]
COLD ISCHEMIA-WARM REPERFUSION (CI/WR) INJURY OF RAT LIVERS: RESPECTIVE ROLE
OF INHIBITION OF MITOCHONDRIAL PERMEABILITY TRANSITION PORE (MPTP) OPENING AND
OF ANTIOXIDANTS
E Tarrab,
A Brault, P-M Huet
Centre de recherche du CHU Montréal, Hôpital
Saint-Luc, Université de Montréal, Montréal, Québec
[041]
HEMOCONCENTRATION: AN EARLY PREDICTOR OF SEVERE PANCREATITIS
R Lavoie, R Black, J-D Baillargeon
Department of Medicine,
University of Sherbrooke, Sherbrooke, Quebec
[042]
COMPARISON OF HEMATOCRIT (HCT) IN NECROTIZING PANCREATITIS (NP) AND INTERSTITIAL
PANCREATITIS (IP) INDUCED IN RATS
R Lavoie, J Morisset, S Julien, J Lainé,
R Black, J-D Baillargeon
Department of Medicine,
University of Sherbrooke, Sherbrooke, Quebec
[043]
A NOMOGRAM TO PREDICT SUSTAINED VIROLOGIC RESPONSE IN PATIENTS WITH HEPATITIS
C
JS McGrath, P Marotta, PC Adams
Division of Gastroenterology,
University of Western Ontario, London, Ontario
[044]
CLINICAL DIAGNOSIS OF WILSON DISEASE (WD) IN CHILDREN AND YOUNG ADULTS
Carolina Jiménez, Katryn Furuya, Antony
Otley (Halifax), Garth Bruce (Saskatoon), Eve A Roberts
Division of Gastroenterology
and Nutrition, The Hospital for Sick Children and University of Toronto, Toronto,
Ontario
[045]
DURABILITY OF LAMIVUDINE ASSOCIATED HBE ANTIGEN SEROCONVERSION IN CHINESE-CANADIAN
PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION
AS Ramji, EM Yoshida, WCP Kwan
Division of Gastroenterology,
University of British Columbia, Vancouver, British Columbia
[046]
A LOCAL RETROSPECTIVE REVIEW OF PATIENTS WITH HCV INFECTION
CT Dao, G Faust, D Menard, E Frost
CHUS, Sherbrooke, Quebec
[047]
HISTOLOGICAL CRITERIA FOR THE DISTINCTION OF HEPATITIS C RECURRENCE POST LIVER
TRANSPLANTATION IN PATIENTS WITH OTHER HEPATIC COMPLICATIONS
Talat Bessissow, Victoria A Marcus, Marc Deschênes
McGill University Health Center, Montreal,
Quebec
[048]
HCV-INDUCED NEUROCOGNITIVE IMPAIRMENT DOES NOT SEEM TO BE A MAJOR DETERMINANT
OF POOR INTERPERSONAL RELATIONSHIPS IN PATIENTS WITH CHRONIC HEPATITIS C
T La, M Deschênes
Division of Hepatology,
McGill University Health Centre, Montreal, Quebec
[049]
COST AND COST-EFFECTIVENESS OF HEPATITIS C VIRUS (HCV) TREATMENT
M Deschênes1,
J Penrod1, G Pomier-Laryagues2, R Lalonde1,
A Lynch1, M McGregor1, for The Technology Assessment Unit
of McGill University Health Centre (MUHC), Montreal, Quebec
McGill University1,
Université de Montréal 2
[050]
COMBINATION LOW DOSE HEPATITIS B IMMUNOGLOBULIN (HBIG) AND LAMIVUDINE THERAPY
AS EFFECTIVE PROPHYLAXIS AGAINST POST LIVER TRANSPLANT (LT) HEPATITIS B VIRUS
(HBV)
SF Farjalla, P Myers, PJ Marotta
Liver Transplant
Unit, University Campus London Health Sciences Centre, University of Western
Ontario, London, Ontario
[051]
WHICH PATIENTS WITH PRIMARY BILIARY CIRRHOSIS OR PRIMARY SCLEROSING CHOLANGITIS
SHOULD UNDERGO ENDOSCOPIC SCREENING FOR ESOPHAGEAL VARICES DETECTION?
B Bressler,
D El-Ashry, EJ Heathcote
University Health
Network, Toronto, Ontario
[052]
IMPLICATION OF MITOCHONDRIAL DYSFUNCTION AND APOPTOSIS IN COLD PRESERVATION/WARM
REPERFUSION-INDUCED HEPATOCYTE INJURY
AI Ghoneim, A Elimadi, PS Haddad
Department of Pharmacology
and Membrane Transport Research Group, Université de Montréal,
Montréal, Québec
[053]
AT-130: A NOVEL INHIBITOR OF HBV REPLICATION
JJ Feld1,2, D Colledge1,
P Sozzi1, G Painter3, SA Locarnini1
1Victoria
Infectious Diseases Reference Laboratory, Melbourne, Australia; 2University
of Toronto, Department of Medicine, Toronto, Ontario; 3Triangle Pharmaceuticals,
Durham, North Carolina, USA
[054]
TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) BEFORE SURGERY IN CIRRHOTIC
PATIENTS: A RETROSPECTIVE COMPARATIVE STUDY
E Vinet, P Perreault, L Bouchard, D Bernard, R Wassef,
C Richard, G Pomier-Layrargues
Centre Hospitalier de l'Université de
Montréal, Hôpital Saint-Luc, Montréal, Québec
[055]
VIRAL HEPATITIS: A STRONG PREDICTOR OF OSTEOPOROSIS IN END-STAGE LIVER DISEASE
Jill McDermid, Winnie Wong, Mang Ma, Constance
Chik
University
of Alberta, Edmonton, Alberta
[056]
CLINICAL UTILIZATION OF EUS BY REFERRING PHYSICIANS WITH OPEN ACCESS TO EXPERT
EUS -
A TWO YEAR ANALYSIS
SC Paquin, AV Sahaï
Department of Medicine,
CHUM - Hôpital Saint-Luc, Université de Montréal, Montréal,
Québec
[057]
THE MORBIDITY OF SYMPTOMATIC CRYOGLOBULINEMIA AND HEPATITIS C AND RESPONSE TO
THERAPY
S Joshi, EJ Heathcote
Toronto Western Hospital,
Toronto, Ontario
[058]
REINFORCED AND ACCELERATED HEPATITIS B IMMUNIZATION IN PATIENTS WITH DECOMPENSATED
CIRRHOSIS: AN INTERIM ANALYSIS OF A RANDOMIZED TRIAL OF INTRADERMAL VERSUS INTRAMUSCULAR
VACCINATION
E Lam, VG Bain, D Bigam, C Campbell, NM Kneteman,
MM Ma, AM Shapiro, A Taskinen, WWS Wong, KS Gutfreund
Departments of
Medicine and Surgery, University of Alberta, Edmonton, Alberta
[059]
DOES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNTS (TIPS) INCREASE THE RISK
FOR THE GROWTH OF HEPATOCELLULAR CARCINOMA?
V Thien, L Lilly, L Blendis, F Wong
Department
of Medicine, University of Toronto, Toronto, Ontario